The phagocyte NADPH oxidase, dormant in resting cells, is activated during phagocytosis to produce superoxide, a precursor of microbicidal oxidants. The activated oxidase is a complex of membrane-integrated cytochrome bs58, composed of 91-kDa (gp91PbOx) and 22-kDa (p22PIox) subunits, and two cytosolic factors (p47PbOX and p67Pb°'), each containing two Src homology 3 (SH3) domains.
tochrome bs58, composed of 91-kDa (gp91PbOx) and 22-kDa (p22PIox) subunits, and two cytosolic factors (p47PbOX and p67Pb°'), each containing two Src homology 3 (SH3) domains.
Here we show that the region of the tandem SH3 domains of p47Phox (p47-SH3) expressed as a glutathione S-transferase fusion protein inhibits the superoxide production in a cell-free system, indicating involvement of the domains in the activation. Furthermore, we find that arachidonic acid and sodium dodecyl sulfate, activators of the oxidase in vitro, cause exposure of p47-SH3, which has probably been masked by the C-terminal region of this protein in a resting state. The unmasking of p47-SH3 appears to play a crucial role in the assembly of the oxidase components, because p47-SH3 binds to both p22PhO and p67PhOx but fails to interact with a mutant p22Phox carrying a Pro-156 -* Gln substitution in a prolinerich region, which has been found in a patient with chronic granulomatous disease. Based on the observations, we propose a signal-transducing mechanism whereby normally inaccessible SH3 domains become exposed upon activation to interact with their target proteins.
During ingestion of microbes or upon stimulation with various soluble molecules, neutrophils and other phagocytic cells produce superoxide (O°), a precursor of microbicidal oxidants (1) (2) (3) (4) . The process involves activation ofthe phagocyte NADPH oxidase, dormant in resting cells, that catalyzes reduction of molecular oxygen to superoxide in conjunction with oxidation of NADPH. The significance of the NADPH oxidase in host defense is made evident by recurrent and life-threatening infections that occur in patients with chronic granulomatous disease (CGD) whose phagocytes lack the superoxide-producing system (1) (2) (3) (4) .
The active NADPH oxidase is found on the phagocyte membrane as an enzyme complex, the components ofwhich are identified as targets of genetic defects causing CGD. The one identified at an earlier stage is a phagocyte-specific membrane-integrated b-type cytochrome, cytochrome b558 (5-11), composed of 91-kDa and 22-kDa subunits (designated gp91Phox and p22PhOX, respectively). The cytochrome is now considered to be a flavocytochrome comprising an apparatus transporting electrons from NADPH via FAD and then heme to molecular oxygen (12) (13) (14) (15) (16) . Identification of other oxidase components has advanced by development of a cell-free activation system reconstituted with both membrane and cytosolic fractions of phagocytes in the presence of arachidonic acid or sodium dodecyl sulfate (SDS) (17) . Three cytosolic proteins are required for the cell-free activation of the oxidase, two ofwhich (designated p47phox and p67Phox) have been identified by their absence in patients with CGD (18) (19) (20) (21) . In addition to these specialized factors, as a third cytosolic factor, the small GTPbinding protein p21rac (rac 1 and/or rac 2) is also involved in the system (22) (23) (24) .
Although the components of the NADPH oxidase are thus identified, little is known about the mechanism for their assembly leading to activation of the enzyme. Upon phagocyte stimulation, the cytosolic components translocate to the membrane where cytochrome b558 resides (25, 26) . Experiments using neutrophils from CGD patients have revealed that the translocation of p47Phox and p67Ph°x requires interaction between P7PhOx and cytochrome b558 (25) (27) (28) (29) (30) (31) (32) . We focused on the role of the SH3 domains of p47PhOX in assembly and activation of the phagocyte NADPH oxidase.
In the present study, we show that activation of the phagocyte NADPH oxidase involves interaction through the SH3 domains of p47phox. Arachidonic acid and SDS, activators of the oxidase in vitro, cause exposure of the SH3 domains of p47PhOx, which seem to have been masked by the C-terminal region of the protein in a dormant state. Furthermore, we find that the exposed SH3 domains of p47PhOx bind to both p22PhOX and p67Phox and that a point mutation in p22Phox (Pro-156 --Gln substitution in a proline-rich region), which has been reported in a patient with CGD (33) , results in loss of the interaction. Based on the observations, we propose a signal-transducing mechanism through SH3 domains: normally inaccessible SH3 domains become exposed upon activation to interact with their target proteins.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. in the cell-free system. Human neutrophil NADPH oxidase was activated in the presence ofGST-p47-SH3 or GST alone. The rate of superoxide production in the absence of the GST proteins was 383 ± 7 nmol/min per mg of membrane protein (n = 6), which was set as 100%. Percentage ofrates relative to the control is plotted against the concentrations of GST-p47-SH3 (o) or GST alone (e). The values represent the averages of two independent experiments.
MATERIALS AND METHODS Glutathione S-Transferase (GST) Fusion Proteins. DNA fiagments encoding p47-SH3 (amino acid residues 154-285 of p47PhOx), p47-N (amino acid residues 1-153), and p47-C (amino acid residues 286-390) were amplified by polymerase chain reaction (PCR) from a cloned cDNA encoding human p47Phox, using specific 3' and 5' primers that included restriction sites for BamHI and EcoRI. The PCR products were subcloned into the pGEX-2T expression vector (Pharmacia). The cDNA encoding the cytoplasmic domain of human p22Phox (amino acid residues 132-195), designated as p22 (132-195), was obtained by PCR from a human neutrophil cDNA library. For the fragment encoding p22 (132-195, P156Q), the mutation was introduced into p22 (132-195) by PCR mutagenesis. The DNA fragment encoding p22 (145-170) was constructed by PCR of p22 (132-195). The PCR fiagments were cloned in-frame into the BamHI and EcoRI sites of the pGEX-2T vector. The DNA fragments encoding p22 (151-160) and p22 (151-160, P156Q), were derived from synthetic oligonucleotides, which were cloned into the BamHI and EcoRI sites of the pGEX-2T vector. Sequencing of the constructs to confirm their identity was done with Sequenase according to the manufacturer's protocol (United States Biochemical). The fusion protein was expressed in Escherichia coli and purified by glutathione-Sepharose beads (Pharmacia) according to the manufacturer's protocol.
Assay of NADPH-Dependent Superoxide Production. Mem- brane and cytosolic fractions of human neutrophils were prepared as described (34 MgCl2, and 1.0 mM NaN3. The cytosol (220 pg/ml) and membrane (15 g/mil) were mixed with the indicated concentration of GST-p47-SH3 or GST alone, followed by incubation with an optimal concentration of arachidonic acid (50 jM) or of SDS (100 ,uM) for 2 min at room temperature. The reaction was initiated by addition of NADPH (250 pM) to the reaction mixture, and NADPH-dependent superoxideproducing activity was measured by determining the rate of superoxide dismutase-inhibitable ferricytochrome c reduc- Binding of p47-SH3 to p67PbOx. Human neutrophil cytosol (800 pg) was incubated in buffer B with 200 pmol of GST alone or GST-p47-SH3 in the presence or absence of 50 AM arachidonic acid for 5 min at room temperature. GlutathioneSepharose beads were added to each mixture and incubated for 1 hr at 40C to retrieve the GST fusion proteins, which were then washed four times by PBS. The proteins eluted from the beads with Laemmli sample buffer were subjected to SDS/ PAGE on a 10%o gel and immunoblotted using a monoclonal antibody raised against recombinant human p67Phox that was produced in Sf9 insect cells (35) .
RESULTS AND DISCUSSION
To investigate roles of the SH3 domains of p47Phox, we produced and isolated the fusion protein GST-p47-SH3 and tested its effect on the NADPH oxidase in the presence of 50 ,uM arachidonic acid (Fig. 1) or 100 ,uM SDS (data not shown) in a cell-free system. It is well established that these anionic amphiphiles act as activators in vitro (17) , probably by interacting with components of the oxidase. GST-p47-SH3 inhibited superoxide production in a dose-dependent manner, while GST alone did not affect the production at all (Fig.  1) . This suggests that a protein-protein interaction mediated via p47-SH3 is involved in the activation process of the phagocyte NADPH oxidase.
The involvement of p47-SH3 in the oxidase activation implies that p47Phox may be a target of arachidonic acid and SDS. Interactions with these substances may cause a conformational change in p47Phox, allowing the SH3 domains to associate with other oxidase factors. To test this possibility, we used a monoclonal antibody that specifically recognizes p47-SH3 (Fig. 2A) . Binding of the anti-p47-SH3 antibody to native p47Phox is totally dependent on the presence of arachidonic acid (Fig. 2B) or SDS (data not shown). When GST-p47-SH3 was used instead of native p47phox, the recognition of the SH3 domains by the antibody was independent of arachidonic acid (Fig. 2B) or SDS (data not shown), indicating that these activators did not alter the conformation of the antibody or of p47-SH3 under the condition used. These results strongly suggest that p47-SH3 is normally inaccessible to the antibody but becomes exposed upon addition of the activators. Several recent studies have shown that SH3 domains interact with proline-rich regions of their target proteins (28) (29) (30) (31) (32) . In fact, p47phox itself contains a proline-rich stretch in its C-terminal region. As shown in Fig.  2C , this region clearly possessed the ability to bind to p47-SH3. The result suggests that, in the absence of the activators, p47-SH3 is probably masked by the C-terminal region of p47Phox through an intramolecular cis interaction.
It is likely that the unmasked p47-SH3, in turn, interacts with other oxidase factors to form the active enzyme complex. The large subunit ofcytochrome b558 (gp91Phox) does not appear to contain a binding site for p47-SH3, since it lacks amino acid stretches rich in proline (5-7). Also, the cytosolic small GTP-binding protein p21F, which is implicated in the oxidase activation in addition to p47PhoX and p67Phox (22.24) , and the regulators of p21 (rho GDI and smg GDS) (36, 37) are unlikely to bind to p47-SH3 for the same reason. On the other hand, proline-rich regions do exist in the cytoplasmic domain of p22Phox (11, 38) and the other specialized cytosolic factor p67PhIx (21) .
We first tested the ability of p47-SH3 to bind to the cytoplasmic domain of p22Phox expressed as a GST fusion protein ( Fig. 3 A and B) . GST-p47-SH3 strongly bound to the cytoplasmic domain, while the binding was completely abolished by a single amino acid substitution of Gln for Pro-156 in p22Ph°x. This substitution in p22Pox has been reported in a CGD patient whose cytochrome b558 is normal in appearance and abundance as determined by visible spectroscopy and by immunoblot analyses but is devoid of activity in the cell-free oxidase activation system (33) . Thus, the association ofp47PhOx with p22Ph°x seems to be essential for the activation of the NADPH oxidase. As far as we are aware, there has been no previous report of a genetic disease caused by an impaired protein-protein interaction via an SH3 domain.
To further investigate the importance of the mutated region, we used GST fusion proteins with smaller fiagments derived from p22Ph°x ( Fig. 3 A and B) . A strong binding was observed with the fusion protein that contained the region of amino acids 145-170 ofp22Phox, the sequence ofwhich is well conserved between human and mouse (38) . This region contains a 10-amino acid stretch very rich in proline residues (PPSNPPPRPP, in single-letter amino acid code) resembling the peptide (APTMPPPLPP) that mediates binding of3BP1 to the SH3 domain of c-Abl (30) . p47-SH3 bound to this 10-amino acid core of p22PhOx, but to a lesser extent. Again, the substitution of Gin for Pro-156 (PPSNPQPRPP) resulted in loss of the binding activity. The proline-rich segment thus directly interacts with p47-SH3. The lower binding affinity of the segment may be due to either its altered structure relative to the larger peptides or the absence of another region that contributes to SH3 binding cooperatively with the prolinerich segment.
We next studied the ability of p47-SH3 to interact with the other cytosolic factor p67Phox, which also carries proline-rich stretches. Although p67PhOx failed to interact with p47-SH3 in the absence of arachidonic acid, the addition of arachidonic acid (Fig. 3C ) or SDS (data not shown) caused binding of p67Phox to p47-SH3. The activator-dependent binding of p67PhOx suggests that the conformation ofp67PhOX may also be changed upon activation by a mechanism similar to that for p47PhOx, because p67Phox contains SH3 domains as well. Fig. 4 summarizes the proposed activation mechanism of the phagocyte NADPH oxidase. The activation involves a conformational change ofp47PhOx. Arachidonic acid and SDS break a cis interaction of p47-SH3 with the C-terminal region of this protein, leading to trans interactions with both p22Phox and p67PhOx. In the intact cells, the unmasking of p47PhOx may be caused by a protein modification, such as phosphorylation. Stimulation of the cells indeed causes phosphorylation of p47Phox, which appears to be correlated with its translocation to membrane (39, 40) . Alternatively, arachidonic acid, released from membrane phospholipid upon stimulation, might act as a second messenger to activate p47Phox directly (41) . In this case, it is possible that arachidonic acid also interacts with other proteins. A recent study shows that biologically active lipids including arachidonic acid are capable of disrupting complexation of rho GDI with p21M, which may play a role in modulating the activity ofp2JYa and thus the NADPH oxidase activity (42) . Another unsolved question in the present study is which one of the two SH3 domains of p47PhOx interacts with p22PhOx and which one interacts with p67PhOx. Further investigations are required to understand the precise role of each SH3 domain in the activation process of the phagocyte NADPH oxidase. Finally, the signal-transducing mechanism whereby normally inaccessible SH3 domains become unmasked upon activation to interact with their target proteins may be involved in other signal transduction pathways. Both an SH3 domain and a proline-rich region are carried by several signaling molecules, such as the 85-kDa subunit of phosphatidylinositol 3'-kinase (43) and the Src family protein tyrosine kinase p55bk (44) .
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